Insider Purchases and Analyst Downgrades Pull Amrize in Opposite Directions

Amrize shares near 52-week low, but executives buy stock. Q2 earnings miss, analysts cautious, buybacks continue.

The disconnect could hardly be starker. Amrize's share price sits within striking distance of its 52-week low, yet the building materials group's own executives have been snapping up equity with notable conviction. The stock closed Friday at €38.68, a shade above the 52-week trough of €37.50 set on August 25 — a gap of just 3.1 percent — while the gap to February's 52-week high stands at 31 percent.

The recent slide has been relentless: an 11 percent decline over the past month and an 18 percent drop since the start of the year. Technical indicators reinforce the bearish picture, with the shares trading 10 percent below their 50-day moving average and 16 percent beneath the 200-day average.

Management Bets on the Fundamentals

Against that backdrop, insider activity tells a different story. Samuel J. Poletti, who was named Chief Financial Officer with immediate effect on Monday, had already purchased 2,510 shares at CHF 37.97 on August 17 — a week before stepping into the finance chief role. He succeeds Baris Oran, who resigned for personal reasons, according to a filing with US regulators.

Poletti is far from alone. Jaime Hill, President of Building Materials, acquired 1,500 shares at $47.12 in the first half of August, while Chief People Officer Stephen S. Clark bought 5,260 shares at $47.31. Two additional purchases by board and executive committee members, totaling 6,000 shares, were executed at prices between CHF 38.30 and CHF 38.43. The cluster of insider buying suggests management sees fundamental value that the market is currently discounting.

The Earnings Trigger

The selling pressure traces back to second-quarter results published in late July. Revenue climbed 8.6 percent to $3.494 billion and net income rose 14.4 percent to $476 million, but adjusted earnings per share of $0.88 came in well short of the $0.95 consensus. Adjusted EBITDA grew 5.8 percent to $986 million, missing analyst expectations of roughly $1.010 billion, with the EBITDA margin of 28.2 percent lagging the projected 30.0 percent.

The company did raise its full-year revenue guidance to a range of $12.5 billion to $12.7 billion, up from the previous $12.29 billion to $12.52 billion target. Yet the margin softness — attributed by RBC Capital Markets to pressure in the commercial roofing business and limited near-term pricing power in cement — overshadowed that positive outlook.

Adding to the noise, Amrize made corrections to prior financial reports shortly after the earnings release, related to the deferral of extended warranty obligations from the Duro-Last and Malarkey acquisitions. The company characterized the adjustments as immaterial.

A Wave of Cautious Analyst Calls

The sell-side response has been predominantly cautious. RBC downgraded the stock from "Sector Perform" to "Underperform" on August 10, cutting its price target from $60 to $48 and trimming its 2026 EBITDA forecast from $3.298 billion to $3.199 billion. Truist followed in mid-August with a downgrade to Hold and a $48 target. Bank of America lowered its target to $50 on August 18, and Stephens reduced its price objective to $54.

UBS initiated coverage on Wednesday with a Hold rating, joining the cautious camp. Not everyone is bearish, however: JPMorgan and Deutsche Bank both nudged their price targets slightly higher in Swiss francs and maintained Overweight and Buy recommendations respectively.

Capital Returns and Expansion Continue

Despite the share price weakness, the company has kept returning capital to shareholders. During the second quarter, Amrize repurchased $197 million worth of shares as part of a $1 billion buyback program and paid out $305 million in dividends, including a special dividend of $0.44 per share in May. The regular quarterly dividend of $0.11 per share was paid on Wednesday, with the stock trading ex-dividend on August 18. Total shareholder returns for the quarter reached $502 million.

Operationally, the growth strategy remains on track. The acquisition of Rapid Redi-Mix LLC, a fast-growing concrete producer in the Dallas-Fort Worth area with around 100 employees, closed in late July. The deal complements the expansion of the Midlothian cement plant and the earlier PB Materials acquisition, with management expecting it to become earnings-accretive by 2026. The next earnings report, due November 3, will offer the first indication of whether that integration is delivering.